These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8624637)

  • 41. [Weekly low-dose methotrexate in rheumatoid arthritis. Review of the literature].
    Manganelli P; Troise Rioda W
    Minerva Med; 1993 Oct; 84(10):541-52. PubMed ID: 8247309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel indomethacin/methotrexate/MMP-9 siRNA in situ hydrogel with dual effects of anti-inflammatory activity and reversal of cartilage disruption for the synergistic treatment of rheumatoid arthritis.
    Yin N; Tan X; Liu H; He F; Ding N; Gou J; Yin T; He H; Zhang Y; Tang X
    Nanoscale; 2020 Apr; 12(15):8546-8562. PubMed ID: 32243486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY.
    Boyapati A; Msihid J; Fiore S; van Adelsberg J; Graham NM; Hamilton JD
    Arthritis Res Ther; 2016 Oct; 18(1):225. PubMed ID: 27716324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced production of tissue inhibitor of metalloproteinases by peripheral blood mononuclear cells of rheumatoid arthritis patients responding to methotrexate treatment.
    Seitz M; Dayer JM
    Rheumatology (Oxford); 2000 Jun; 39(6):637-45. PubMed ID: 10888709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
    Abramson SB; Amin A
    Rheumatology (Oxford); 2002 Sep; 41(9):972-80. PubMed ID: 12209029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinoic acid suppresses interleukin 6 production in normal human osteoblasts.
    Ahmed N; Sammons J; Khokher MA; Hassan HT
    Cytokine; 2000 Mar; 12(3):289-93. PubMed ID: 10704257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of concurrent administration of cilostazol and methotrexate in rheumatoid arthritis: pharmacologic and clinical significance.
    Kim HY; Lee SW; Park SY; Baek SH; Lee CW; Hong KW; Kim CD
    Life Sci; 2012 Sep; 91(7-8):250-7. PubMed ID: 22820172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
    Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A
    Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis.
    Nakazawa F; Matsuno H; Yudoh K; Katayama R; Sawai T; Uzuki M; Kimura T
    J Rheumatol; 2001 Aug; 28(8):1800-8. PubMed ID: 11508582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis.
    Chabaud M; Lubberts E; Joosten L; van Den Berg W; Miossec P
    Arthritis Res; 2001; 3(3):168-77. PubMed ID: 11299057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy.
    Uehara R; Suzuki Y; Ichikawa Y
    J Rheumatol; 2001 Feb; 28(2):251-6. PubMed ID: 11246658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression.
    Li YB; Xu P; Xu K; Cai YS; Sun MY; Yang L; Sun J; Lu SM
    Mol Cell Biochem; 2016 Sep; 420(1-2):161-70. PubMed ID: 27522665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro growth rate of fibroblast-like synovial cells is reduced by methotrexate treatment.
    Lories RJ; Derese I; De Bari C; Luyten FP
    Ann Rheum Dis; 2003 Jun; 62(6):568-71. PubMed ID: 12759297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
    Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
    J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
    Zou J; Zhang Y; Thiel A; Rudwaleit M; Shi SL; Radbruch A; Poole R; Braun J; Sieper J
    Rheumatology (Oxford); 2003 Jul; 42(7):846-55. PubMed ID: 12730543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of leflunomide on human cartilage.
    Panico A; Cardile V; Gentile B; Garufi F; Fama' P; Bonfiglio G; Ronsisvalle G
    Farmaco; 2003 Sep; 58(9):983-7. PubMed ID: 13679195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
    Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
    Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
    Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
    Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblasts.
    Yoshida M; Niwa M; Ishisaki A; Hirade K; Ito H; Shimizu K; Kato K; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):351-62. PubMed ID: 15519494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.